BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25905778)

  • 21. Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats.
    Palsamy P; Subramanian S
    Chem Biol Interact; 2009 May; 179(2-3):356-62. PubMed ID: 19059388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of ocular neovascularization-related genes and oxidative stress in diabetic rat eye tissues after resveratrol treatment.
    Yar AS; Menevse S; Dogan I; Alp E; Ergin V; Cumaoglu A; Aricioglu A; Ekmekci A; Menevse A
    J Med Food; 2012 Apr; 15(4):391-8. PubMed ID: 22191573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-hyperlipidemic and anti-peroxidative role of pterostilbene via Nrf2 signaling in experimental diabetes.
    Bhakkiyalakshmi E; Sireesh D; Sakthivadivel M; Sivasubramanian S; Gunasekaran P; Ramkumar KM
    Eur J Pharmacol; 2016 Apr; 777():9-16. PubMed ID: 26921755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin, quercetin and resveratrol attenuates oxidative hepatocellular injury in streptozotocin-induced diabetic rats.
    Elbe H; Esrefoglu M; Vardi N; Taslidere E; Ozerol E; Tanbek K
    Hum Exp Toxicol; 2015 Sep; 34(9):859-68. PubMed ID: 26286521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling.
    Palsamy P; Subramanian S
    Biochim Biophys Acta; 2011 Jul; 1812(7):719-31. PubMed ID: 21439372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats.
    Jang YY; Song JH; Shin YK; Han ES; Lee CS
    Pharmacol Res; 2000 Oct; 42(4):361-71. PubMed ID: 10987997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Resveratrol on Receptor for Advanced Glycation End Products (RAGE) Expression and Oxidative Stress in the Liver of Rats with Type 2 Diabetes.
    Khazaei M; Karimi J; Sheikh N; Goodarzi MT; Saidijam M; Khodadadi I; Moridi H
    Phytother Res; 2016 Jan; 30(1):66-71. PubMed ID: 26467029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol Ameliorates the Components of Hepatic Inflammation and Apoptosis in a Rat Model of Streptozotocin-Induced Diabetes.
    Pektaş MB; Sadi G; Koca HB; Yuksel Y; Vurmaz A; Koca T; Tosun M
    Drug Dev Res; 2016 Feb; 77(1):12-9. PubMed ID: 26748675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol exhibits differential protective effects on fast- and slow-twitch muscles in streptozotocin-induced diabetic rats.
    Chang CC; Yang MH; Tung HC; Chang CY; Tsai YL; Huang JP; Yen TH; Hung LM
    J Diabetes; 2014 Jan; 6(1):60-7. PubMed ID: 23786522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats.
    George N; Kumar TP; Antony S; Jayanarayanan S; Paulose CS
    Br J Nutr; 2012 Oct; 108(8):1410-8. PubMed ID: 22221397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicogenomics of resveratrol in rat liver.
    Hebbar V; Shen G; Hu R; Kim BR; Chen C; Korytko PJ; Crowell JA; Levine BS; Kong AN
    Life Sci; 2005 Apr; 76(20):2299-314. PubMed ID: 15748624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes.
    Rubiolo JA; Mithieux G; Vega FV
    Eur J Pharmacol; 2008 Sep; 591(1-3):66-72. PubMed ID: 18616940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antioxidant role of pterostilbene in streptozotocin-nicotinamide-induced type 2 diabetes mellitus in Wistar rats.
    Amarnath Satheesh M; Pari L
    J Pharm Pharmacol; 2006 Nov; 58(11):1483-90. PubMed ID: 17132211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits.
    Akar F; Pektas MB; Tufan C; Soylemez S; Sepici A; Ulus AT; Gokalp B; Ozturk K; Surucu HS
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):119-31. PubMed ID: 20676927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in expression profiles of antioxidant enzymes in diabetic rat kidneys.
    Sadi G; Eryilmaz N; Tütüncüoğlu E; Cingir Ş; Güray T
    Diabetes Metab Res Rev; 2012 Mar; 28(3):228-35. PubMed ID: 22057777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats.
    Erejuwa OO; Gurtu S; Sulaiman SA; Ab Wahab MS; Sirajudeen KN; Salleh MS
    Int J Vitam Nutr Res; 2010 Jan; 80(1):74-82. PubMed ID: 20533247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: investigation of liver and plasma.
    Seven A; Guzel S; Seymen O; Civelek S; Bolayirli M; Uncu M; Burcak G
    Yonsei Med J; 2004 Aug; 45(4):703-10. PubMed ID: 15344213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of testis through antioxidant action of Mallotus roxburghianus in alloxan-induced diabetic rat model.
    Roy VK; Chenkual L; Gurusubramanian G
    J Ethnopharmacol; 2015 Dec; 176():268-80. PubMed ID: 26549273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment with resveratrol attenuates oxidative stress pro-inflammatory mediators and apoptosis in streptozotocin-nicotinamide-induced diabetic rats.
    Soufi FG; Vardyani M; Sheervalilou R; Mohammadi M; Somi MH
    Gen Physiol Biophys; 2012 Dec; 31(4):431-8. PubMed ID: 23255670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple statistical methods for assessing differential gene expression in microarray data of diabetic model rats to predict the molecular mechanism of atorvastatin on anti-atherogenesis.
    Xu L; Feng B; Wang H; Li X
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):272-9. PubMed ID: 23450332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.